These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35923621)

  • 1. Screening of the Key Genes and Signalling Pathways for Diabetic Nephropathy Using Bioinformatics Analysis.
    Li Z; Feng J; Zhong J; Lu M; Gao X; Zhang Y
    Front Endocrinol (Lausanne); 2022; 13():864407. PubMed ID: 35923621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the Mechanism of Complement System in Diabetic Nephropathy via Bioinformatics Analysis.
    Xu B; Wang L; Zhan H; Zhao L; Wang Y; Shen M; Xu K; Li L; Luo X; Zhou S; Tang A; Liu G; Song L; Li Y
    J Diabetes Res; 2021; 2021():5546199. PubMed ID: 34124269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis.
    Hu Y; Yu Y; Dong H; Jiang W
    PeerJ; 2023; 11():e15437. PubMed ID: 37250717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seven basement membrane-specific expressed genes are considered potential biomarkers for the diagnosis and treatment of diabetic nephropathy.
    Gui H; Chen X; Ye L; Ma H
    Acta Diabetol; 2023 Apr; 60(4):493-505. PubMed ID: 36627452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Bioinformatics and Clinical Correlation Analysis of Key Genes, Pathways, and Potential Therapeutic Agents Related to Diabetic Nephropathy.
    Chen S; Chen L; Jiang H
    Dis Markers; 2022; 2022():9204201. PubMed ID: 35637650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
    Guo M; Dai Y; Jiang L; Gao J
    Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Lipotoxicity-Related Biomarkers in Diabetic Nephropathy Based on Bioinformatic Analysis.
    Nie H; Yang H; Cheng L; Yu J
    J Diabetes Res; 2024; 2024():5550812. PubMed ID: 38774257
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of key biomarkers in diabetic nephropathy via bioinformatic analysis.
    Zeng M; Liu J; Yang W; Zhang S; Liu F; Dong Z; Peng Y; Sun L; Xiao L
    J Cell Biochem; 2019 May; 120(5):8676-8688. PubMed ID: 30485525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative analyses of biomarkers and pathways for diabetic nephropathy.
    Li B; Zhao X; Xie W; Hong Z; Zhang Y
    Front Genet; 2023; 14():1128136. PubMed ID: 37113991
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of mitochondria-related genes as diagnostic biomarkers for diabetic nephropathy and their correlation with immune infiltration: New insights from bioinformatics analysis.
    Yan Q; Du Y; Huang F; Zhang Q; Zhan M; Wu J; Yan J; Zhang P; Lin H; Han L; Huang X
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113114. PubMed ID: 39265357
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Wang X; Li R; Liu T; Jia Y; Gao X; Zhang X
    Endocr Metab Immune Disord Drug Targets; 2023; 23(3):294-303. PubMed ID: 35713142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.
    Gholaminejad A; Fathalipour M; Roointan A
    BMC Nephrol; 2021 Jul; 22(1):245. PubMed ID: 34215202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of fibronectin 1 (FN1) and complement component 3 (C3) as immune infiltration-related biomarkers for diabetic nephropathy using integrated bioinformatic analysis.
    Wang Y; Zhao M; Zhang Y
    Bioengineered; 2021 Dec; 12(1):5386-5401. PubMed ID: 34424825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of tubulointerstitial genes and ceRNA networks involved in diabetic nephropathy via integrated bioinformatics approaches.
    Cao H; Rao X; Jia J; Yan T; Li D
    Hereditas; 2022 Sep; 159(1):36. PubMed ID: 36154667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of pyroptosis-related genes and potential drugs in diabetic nephropathy.
    Yan M; Li W; Wei R; Li S; Liu Y; Huang Y; Zhang Y; Lu Z; Lu Q
    J Transl Med; 2023 Jul; 21(1):490. PubMed ID: 37480090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets.
    Hojjati F; Roointan A; Gholaminejad A; Eshraghi Y; Gheisari Y
    Nefrologia (Engl Ed); 2023; 43(5):575-586. PubMed ID: 36681521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Biomarkers Related to Th17 Cells in Macular Edema of Diabetic Retinopathy: Cutting-Edge Comprehensive Bioinformatics Analysis and
    Huang J; Zhou Q
    Front Immunol; 2022; 13():858972. PubMed ID: 35651615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of biomarkers and prediction of upstream miRNAs in diabetic nephropathy.
    Yin D; Guo Z; Zhang X
    Front Endocrinol (Lausanne); 2023; 14():1144331. PubMed ID: 36896170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Hub Genes Involved in Tubulointerstitial Injury in Diabetic Nephropathy by Bioinformatics Analysis and Experiment Verification.
    Yang J; Peng L; Tian Y; Tang W; Peng L; Ning J; Li D; Peng Y
    J Immunol Res; 2022; 2022():7907708. PubMed ID: 35991124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying potential biomarkers for the diagnosis and treatment of IgA nephropathy based on bioinformatics analysis.
    Li X; Zeng M; Liu J; Zhang S; Liu Y; Zhao Y; Wei C; Yang K; Huang Y; Zhang L; Xiao L
    BMC Med Genomics; 2023 Mar; 16(1):63. PubMed ID: 36978098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.